This study is looking at how well and how safely NeoThelium FT works for people with venous leg ulcers. NeoThelium FT is a wound covering made from donated human placental tissue. We are looking for about 10 adults, aged 18 or older, who have a venous leg ulcer that is not infected and is between 1 and 30 square centimeters in size. The main goal is to see if the ulcers completely close within 1 to 12 weeks. This study is currently unclear on its recruitment status, but it will help gather information on the effectiveness of NeoThelium FT.

Study design

This is an interventional study where all participants will receive NeoThelium FT. Both you and the study team will know which treatment is being used (open-label).

What's involved

If you join, you will receive weekly applications of NeoThelium FT in addition to standard care. You will continue follow-up according to the original schedule.

Compensation

Not stated in the trial record.

Follow-up

The study will follow participants to see if their wounds close completely within 1 to 12 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.